ArticleNature communications2021

Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer.

Zhiyong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.